Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Mike S. Newton, CIM FCSIPowerShares Bio&Genome ETFPBEPAST TOP PICKDec 01, 2010

(A Top Pick Feb 2/10. Up 14.99%.) Still likes. Thinks its time is due.
$20.36

Stock price when the opinion was issued

$84.10

As of Jun 12, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK
(A Top Pick Feb 2/10. Up 19.34%.) Bio & Genome ETF. For 10 years biotech has been doing nothing but tech has been dong lots. Expects there will be a rediscovery of the space. Safe way to play the pharmacy space.
TOP PICK
Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.
BUY
This is a basket approach to biotechs and should be considered as a long-term hold. Good price.
PAST TOP PICK
(A Top Pick Feb 23/06. Down 16%.) When the market gets nervous, speculative stocks get hit. A long-term holding because it is a basket of biotech companies. Over time, it should give investors a good long term return.
PAST TOP PICK
(A Top Pick Feb 25/06. Down 6%.) A long-term hold. This is a basket of biotech shares.
TOP PICK
This is a way of getting into biotech without having to invest in a single company.